Evidence map›Paper›PMID 35145133›Full record

ArticleScientific reports2022

Gadolinium-oxide nanoparticles for cryogenic magnetocaloric applications.

A Zeleňáková, P Hrubovčák, A Berkutova, O Šofranko, N Kučerka, O Ivankov, A Kuklin, V Girman, V Zeleňák

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. 2D Co-Mo-Hydroxide-Based Multifunctional Material for the Development of HAdvanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

A ZeleňákováInstitute of Physics, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia. adriana.zelenakova@upjs.sk.
P HrubovčákInstitute of Physics, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia.
A BerkutovaInstitute of Physics, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia.
O ŠofrankoInstitute of Physics, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia.
N KučerkaFrank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Joliot-Curie 6, Dubna, Russia, 141980.
O IvankovFrank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Joliot-Curie 6, Dubna, Russia, 141980.
A KuklinFrank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Joliot-Curie 6, Dubna, Russia, 141980.
V GirmanInstitute of Physics, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia.
V ZeleňákInstitute of Chemistry, Faculty of Science, P.J. Šafárik University, Moyzesova 11, 041 54, Košice, Slovakia.

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-20-0512Joint Institute for Nuclear Research 04-4-1133-2018/2020Ministery of Education Slovakia TRIANGELVedecká Grantová Agentúra MŠVVaŠ SR a SAV No. 1/0743/19Vedecká Grantová Agentúra MŠVVaŠ SR a SAV No. 1/0829/21
6 · The paper itself

Abstract

The series of advanced nanocomposites consisting of Gd

Identifiers

PMID35145133
PMCPMC8831503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.